tetano
Editor, Senior Moderator
Int J Environ Res Public Health
. 2021 Apr 5;18(7):3786.
doi: 10.3390/ijerph18073786.
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
Tatsuya Yoshihara[SUP] 1 [/SUP], Kazuya Ito[SUP] 2 3 [/SUP], Masayoshi Zaitsu[SUP] 4 [/SUP], Eunhee Chung[SUP] 5 [/SUP], Izumi Aoyagi[SUP] 6 [/SUP], Yoshikazu Kaji[SUP] 7 [/SUP], Tomomi Tsuru[SUP] 8 [/SUP], Takuma Yonemura[SUP] 9 [/SUP], Koji Yamaguchi[SUP] 10 [/SUP], Shinichi Nakayama[SUP] 11 [/SUP], Yosuke Tanaka[SUP] 12 [/SUP], Nobuo Yurino[SUP] 13 [/SUP], Hideki Koyanagi[SUP] 14 [/SUP], Shunji Matsuki[SUP] 1 [/SUP], Ryuji Urae[SUP] 15 [/SUP], Shin Irie[SUP] 15 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03-0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.
Keywords: COVID-19; SARS-CoV-2; antibody; healthcare workers; seroprevalence.
. 2021 Apr 5;18(7):3786.
doi: 10.3390/ijerph18073786.
SARS-CoV-2 Seroprevalence among Healthcare Workers in General Hospitals and Clinics in Japan
Tatsuya Yoshihara[SUP] 1 [/SUP], Kazuya Ito[SUP] 2 3 [/SUP], Masayoshi Zaitsu[SUP] 4 [/SUP], Eunhee Chung[SUP] 5 [/SUP], Izumi Aoyagi[SUP] 6 [/SUP], Yoshikazu Kaji[SUP] 7 [/SUP], Tomomi Tsuru[SUP] 8 [/SUP], Takuma Yonemura[SUP] 9 [/SUP], Koji Yamaguchi[SUP] 10 [/SUP], Shinichi Nakayama[SUP] 11 [/SUP], Yosuke Tanaka[SUP] 12 [/SUP], Nobuo Yurino[SUP] 13 [/SUP], Hideki Koyanagi[SUP] 14 [/SUP], Shunji Matsuki[SUP] 1 [/SUP], Ryuji Urae[SUP] 15 [/SUP], Shin Irie[SUP] 15 [/SUP]
Affiliations
- PMID: 33916399
- DOI: 10.3390/ijerph18073786
Abstract
Coronavirus disease 2019 (COVID-19) has become a serious public health problem worldwide. In general, healthcare workers are considered to be at higher risk of COVID-19 infection. However, the prevalence of COVID-19 among healthcare workers in Japan is not well characterized. In this study, we aimed to examine the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among 2160 healthcare workers in hospitals and clinics that are not designated to treat COVID-19 patients in Japan. The prevalence of SARS-CoV-2 immunoglobulin G was 1.2% in August and October 2020 (during and after the second wave of the pandemic in Japan), which is relatively higher than that in the general population in Japan (0.03-0.91%). Because of the higher risk of COVID-19 infection, healthcare workers should be the top priority for further social support and vaccination against SARS-CoV-2.
Keywords: COVID-19; SARS-CoV-2; antibody; healthcare workers; seroprevalence.